Worldwide eczema study aims to uncover disparities in care
NCT ID NCT07659756
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This international study observes how people with atopic dermatitis (eczema) access healthcare, what treatments they receive, and how the disease affects their daily lives. Researchers will collect data from routine medical records of about 9,600 participants across multiple countries. The goal is to identify differences in care and outcomes that could lead to better, more equitable treatment for everyone with eczema.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- This study could reveal gaps in care and help improve treatment strategies for people with eczema worldwide.
- What could go wrong
- As an observational study, it does not test a new treatment, so it cannot directly lead to a cure or new therapy.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATOPIC DERMATITIS (AD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Zurich
RECRUITINGZurich, Switzerland
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can ozonated oil soothe eczema in kids?
- Can a Skin-Repairing cream soothe eczema?
- Can a new antibody calm severe eczema?
- Can a new drug safely control eczema over the long haul?
- Microscopic skin scans may reveal how a new eczema drug reshapes the skin
- Menthol gloves may offer quick itch relief for eczema sufferers